Yeramian Patrick D

Yeramian Patrick D serves as the Chief Medical Officer at Amylyx Pharmaceuticals, Inc., a company focused on developing innovative therapies for neurological diseases. On January 11, 2024, he reported a sale of shares valued at approximately $45.9K, marking his first disclosed transaction. This activity is part of a public disclosure record that highlights his role within the healthcare sector and provides insights into his recent financial decisions.